SGLT2 Inhibitors for Diabetes May Protect Against AKI, Incre

With increasing use of sodium glucose cotransporter 2 (SGLT2) inhibitors, investigators are taking a closer look at potential adverse events.

Related Keywords

Germany , Australia , Japan , United States , Kaseda , Kagoshima , Massachusetts , Boston , South Korea , Japanese , American , Korea , Brian Chiang , Mitsuboshi Satoru , Bonggi Kim , Jan Menne , Korean National Health Insurance Service , Flinders Medical Centre , International Journal Of Cardiology , Pharmacology Research Perspectives , Hannover Medical School In , Korea Institute Of Drug Safety , Harvard Medical School , Hannover Medical School , American Journal , Kidney Disease , Elisabetta Patorno , Event Reporting System , Kaetsu Hospital , Medical Data Vision , Korea Institute , Drug Safety , Risk Management , Pharmacology Research , International Journal , Pharmacol Res ,